Demographics and Prevalence of Comorbidities for Patients with Mild, Moderate, and Severe Psoriasis

被引：0
|
作者：
Hajiebrahimi, Mohammadhossein [1 ]
Sundstrom, Anders [1 ]
Hagg, David [1 ]
McElligott, Sean [2 ]
Valgardsson, Sverrir [3 ]
Villacorta, Reginald [2 ]
Linder, Marie [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Janssen Co, Raritan, NJ USA
[3] Janssen Co, Beerse, Belgium
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
630
引用
收藏
页码：379 / 380
页数：2
相关论文
共 50 条
  • [21] High prevalence of cardiovascular risk factors in patients with moderate or severe psoriasis in northern China
    Ma, Liangjuan
    Li, Me
    Wang, Hefei
    Li, Yuzhen
    Bai, Bingxue
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2014, 306 (03) : 247 - 251
  • [22] Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis
    Langewouters, A. M. G.
    van Erp, P. E. J.
    de Jong, E. M. G. J.
    de Kerkhof, P. C. M. van
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2008, 300 (03) : 107 - 113
  • [23] Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis
    A. M. G. Langewouters
    P. E. J. van Erp
    E. M. G. J. de Jong
    P. C. M. van de Kerkhof
    Archives of Dermatological Research, 2008, 300 : 107 - 113
  • [24] Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: Effect of Demographics and Baseline Disease Characteristics on Efficacy
    Imafuku, Shinichi
    Tada, Yayoi
    Umezawa, Yoshinori
    Sakurai, Shinya
    Hoshii, Naoki
    Nakagawa, Hidemi
    DERMATOLOGY AND THERAPY, 2022, 12 (01) : 121 - 135
  • [25] Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: Effect of Demographics and Baseline Disease Characteristics on Efficacy
    Shinichi Imafuku
    Yayoi Tada
    Yoshinori Umezawa
    Shinya Sakurai
    Naoki Hoshii
    Hidemi Nakagawa
    Dermatology and Therapy, 2022, 12 : 121 - 135
  • [26] COST OF MODERATE TO SEVERE PSORIASIS PATIENTS IN SPAIN
    Sanchez-Carazo, J. L.
    Dauden, E.
    Vanaclocha, F.
    Toribio, J.
    Pujol, R.
    Puig, L.
    Yebenes, M.
    Sabater, F. J.
    VALUE IN HEALTH, 2009, 12 (07) : A454 - A454
  • [27] Costeffectiveness of alefacept in patients with moderate to severe psoriasis
    Jorstad, IC
    Haugli, K
    Eggen, E
    Kristiansen, IS
    VALUE IN HEALTH, 2003, 6 (06) : 788 - 788
  • [28] Treatment changes in patients with moderate to severe psoriasis
    Anderson, Kathryn
    Feldman, Steven
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB256 - AB256
  • [29] The transition from mild to moderate-to-severe chronic plaque psoriasis
    Bellinato, Francesco
    Gisondi, Paolo
    Mioso, Guido
    Mason, Elena
    Straiotto, Danny
    Piaserico, Stefano
    Girolomoni, Giampiero
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (10) : E1215 - E1217
  • [30] THE PREVALENCE OF THE "LOW-FLOW" PHENOMENON IN PATIENTS WITH MILD, MODERATE AND SEVERE AORTIC STENOSIS
    Lee, Glenn Kay Mun
    Tay, Edgar L.
    Yeo, Tiong Cheng
    Poh, Kian Keong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1940 - E1940
12345